In gastric cancer, NR2F1-AS1 enhances cell growth through various axes, including miR-29a/VAMP7 [28], miR-190a/PHLDB2/AKT3 [29], SPI1/ST8SIA1 [30], and miR-493-5p/MAP3K2 [31]. This evidence concerns the gene MAP3K2 and gastric cancer.